Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.002 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.21 | 0.004 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |